Resonate
Payments companies reported to CMS as associated with Resonate. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Resonate, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Resonate
These are the largest totals companies reported as associated with Resonate. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nima Salari | Phoenix, AZ | Orthopaedic Surgery of The Spine | $36,350.18 |
| Mark Adams | Saginaw, MI | Clinical Genetics (M.D.) | $36,350.18 |
| Jeffrey Rihn | Malvern, PA | Orthopaedic Surgery | $36,350.18 |
| Samuel Cho | New York, NY | Orthopaedic Surgery | $36,350.18 |
| Samer Ghostine | Los Angeles, CA | Neurological Surgery | $36,350.18 |
| Brian Danshaw | Fort Worth, TX | Orthopaedic Surgery of The Spine | $121.33 |
| Lee Kripke | Philadelphia, PA | Orthopaedic Surgery | $70.90 |
| Grant Booher | Fort Worth, TX | Neurological Surgery | $66.50 |
| Rishi Lall | Galveston, TX | Neurological Surgery | $49.43 |
| Brian Oliver | Galveston, TX | Neurological Surgery | $33.66 |
Prescribed Resonate?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.